Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 6/1/1998


1.		Phase III Randomized Study of TNP-470 vs Synchronous Radiotherapy and 5-FU/CF for Locally Advanced Nonresectable Nonmetastatic Pancreatic Cancer (Summary Last Modified 06/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				MSKCC-96018 NCI-V96-0876

Last Modified: 5/1/1997


2.		Phase II Study of TNP-470 in Newly Diagnosed, Previously Irradiated Glioblastoma Multiforme (Summary Last Modified 05/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				DFCI-95115 NCI-V96-0866

Last Modified: 12/1/1998


3.		Phase II Study of TNP-470 for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix (Summary Last Modified 12/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				MDA-DM-96157 TAP-MDA-DM-96157, NCI-V96-1097

Last Modified: 7/1/1994


4.		Phase I Study of TNP-470, an Inhibitor of Angiogenesis, in Patients with Advanced Solid Tumors (Summary Last Modified 07/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				DFCI-93102 NCI-T93-0140D, T93-0140

Last Modified: 5/2/2007


5.		Phase I Study of TNP-470 in Relapsed/Refractory Pediatric Solid Tumors and Lymphoma (Summary Last Modified 08/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				under 18				NCI				DFCI-93146 NCI-T93-0139D, T93-0139

Last Modified: 7/1/1999 First Published: 10/1/1997


6.		Phase I Study of TNP-470 in Patients with Recurrent or Refractory Pediatric Solid Tumors, Lymphomas, and Acute Leukemias (Summary Last Modified 07/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				2 to 21				Pharmaceutical / Industry				MSKCC-97072 TAP-MSKCC-97072, NCI-G97-1310

Last Modified: 7/1/1997


7.		Phase I Pilot Study of TNP-470 in Patients with HIV-Associated Kaposi's Sarcoma (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				NCI-92-C-0228M NCI-T92-0041N, T92-0041

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute